Polyrizon Ltd. (PLRZ)
AI Score
Our AI model analyzes fundamental, technical, and statistical indicators
to predict the probability of a bullish trend over the next three months.
We regularly update and refine our models to deliver the most reliable forecasts
for you.
Bullish Probability | Sentiment | Score |
---|---|---|
+80% | Strong Buy | 10 |
+75% | Buy | 9 |
+70% | Buy | 8 |
+60% | Buy | 7 |
+50% | Hold | 6 |
+45% | Hold | 5 |
+40% | Hold | 4 |
+35% | Sell | 3 |
+30% | Sell | 2 |
+20% | Strong Sell | 1 |
1.01
-0.11 (-9.82%)
At close: Feb 10, 2025, 3:59 PM
1.03
1.98%
After-hours Feb 10, 2025, 07:55 PM EST
undefined% (undefined)
Bid | 1.01 |
Market Cap | 4.24M |
Revenue (ttm) | - |
Net Income (ttm) | - |
EPS (ttm) | -0.24 |
PE Ratio (ttm) | -4.21 |
Forward PE | n/a |
Analyst | n/a |
Ask | 1.06 |
Volume | 122,305 |
Avg. Volume (20D) | 2,987,900 |
Open | 1.01 |
Previous Close | 1.12 |
Day's Range | 1.00 - 1.09 |
52-Week Range | 0.77 - 4.80 |
Beta | undefined |
About PLRZ
Polyrizon Ltd., a biotech company, engages in the development of medical device hydrogels in the form of nasal sprays in Israel. The company's nasal sprays provide a barrier against viruses and allergens from contacting the nasal epithelial tissue. It develops PL-14, a nasal allergies blocker; PL-15 for COVID-19; and PL-16 for influenza. The company was incorporated in 2005 is headquartered in Ra'anana, Israel....
Industry Biotechnology
Sector Healthcare
IPO Date Oct 29, 2024
Employees 1
Stock Exchange NASDAQ
Ticker Symbol PLRZ
Why Price Moved
1 month ago
+31.71%
Polyrizon shares are trading higher after the comp...
Unlock content with
Pro Subscription
1 month ago
+213.33%
PolyRizon shares are trading higher after the company announced it secured a GMP partnership with Eurofins CDO Amatsiaquitaine.